Patents by Inventor Jennifer Giltnane

Jennifer Giltnane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for determining signal transduction activity in tumors
    Patent number: 8497080
    Abstract: The method of the invention pertains to determining signal transduction activity in a tissue section by immunohistochemistry techniques. The expression level of the receptor of interest is determined as well as the expression levels of one or more effector molecules of the receptor signal transduction pathway. Furthermore a combined ratio of expression levels of effector molecules in subcellular compartments with the receptor expression was found to have prognostic significance.
    Type: Grant
    Filed: February 5, 2013
    Date of Patent: July 30, 2013
    Assignees: HistoRx, Inc., Yale University
    Inventors: Mark Gustavson, Jennifer Giltnane, Marisa P. Dolled-Filhart, Robert L. Camp, David L. Rimm
  • Methods for determining signal transduction activity in tumors
    Patent number: 8367351
    Abstract: The method of the invention pertains to determining the signal transduction activity in a tissue section by immunohistochemistry techniques. The expression level of the receptor of interest is determined as well as the expression levels of one or more effector molecules of the receptor signal transduction pathway. Furthermore a combined ratio of expression levels of effector molecules in subcellular compartments with the receptor expression was found to have prognostic significance.
    Type: Grant
    Filed: May 7, 2007
    Date of Patent: February 5, 2013
    Assignees: Historx, Inc., Yale University
    Inventors: Mark Gustavson, Jennifer Giltnane, Marisa P. Dolled-Filhart, Robert L. Camp, David L. Rimm
  • METHODS FOR DETERMINING SIGNAL TRANSDUCTION ACTIVITY IN TUMORS
    Publication number: 20100062452
    Abstract: The method of the invention pertains to determining the signal transduction activity in a tissue section by immunohistochemistry techniques. The expression level of the receptor of interest is determined as well as the expression levels of one or more effector molecules of the receptor signal transduction pathway. Furthermore a combined ratio of expression levels of effector molecules in subcellular compartments with the receptor expression was found to have prognostic significance.
    Type: Application
    Filed: May 7, 2007
    Publication date: March 11, 2010
    Applicants: Yale University, HistoRx, Inc.
    Inventors: Mark Gustavson, Jennifer Giltnane, Marisa P. Dolled-Filhart, Robert L. Camp, David L. Rimm